Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page
- Check6 days agoChange DetectedThe Related Topics section no longer lists 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' for this study; these are ancillary topics and do not affect core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedA single 'Locations' section now lists all study sites across the US, Canada, Australia, and India, consolidating what were previously separate location blocks.SummaryDifference1%

- Check20 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the study page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedFooter revision label updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check42 days agoChange DetectedThe additions primarily add publication notes (voluntary input and PubMed autofill) and a new Revision: v3.3.1, while deletions remove older related topics and an older revision note (Revision: v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedA new study site was added: Tainan, Taiwan, 7428, and the old site entry Tainan City, Taiwan, 7428 was removed along with a funding-status notice.SummaryDifference0.1%

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.